CAR-T Therapy in Action
Helping the Immune System Recognize and Eliminate Cancer Cells
Advancing CAR-T Therapy Through High-Performance Vector Solutions
The Tailored Genes team supports the next generation of CAR-T innovation with viral vectors built for performance, consistency, and real-world transduction success. We help researchers develop and scale advanced cell therapies by providing reliable vector solutions that reduce variability andaccelerate progress from early-stage development through manufacturing.
Supporting High Quality Technology for CAR-T Therapy
Successful CAR-T development depends on efficient and consistent gene delivery into T cells to achieve predictable expression and function. High-quality viral vectors help reduce variability, improve transduction outcomes, and support scalable manufacturing workflows, making them essential for reliable process development, and next-generation cell therapy advancement.
Why Researchers Choose Tailored Genes
Reliable Transduction Performance
We focus on functional outcomes that drive meaningful research results, not just “high numbers”. Or not just vector titers.
Collaborative Scientific Support
Our team works as an extension of yours, not asa vendor, rather a partner in providing responsive communication and project focussed guidance.
Cell Therapy Expertise
We understand the speed, complexity, and precision required forCAR-T development programs.
Lentiviral + AAV capability
We support the vector platforms commonly used across gene and cell therapy research.
CAR-T SERVICES
How CAR-T Therapy Works
CAR-T therapy uses a patient’s own immune cells, which are engineered to recognize and attack cancer cells more effectively.
01.
T-cells are collected
T cells are isolated from the patient’s blood through a specialized collection process called leukapheresis
02.
The cells are engineered
In a specialized lab, those T cells are genetically modified to expressa new Chimeric Antigen Receptor (the CAR) which recognize specific targets on cancer cells.
03.
The engineered T-cells are expanded
Once the cells have been modified, they’re grown and multiplied to generatesufficientcells for treatment.
04.
The CAR-T cells are reinfused back into the patient
The modifiedT cells go back into the patient’s body through infusion.
05.
The CAR-T cells hunt cancer cells
Now, once inside the body, the engineered CAR-T cells can identify, engage and attack cancer cellsmore effectively.
Vector Quality Matters in CAR-T Research and Development
Precision is essential in CAR-T development.
Whether supporting discovery research, process optimization, or translational programs, researchers need vector systemsthat perform consistently and predictably across experiments
High-Quality reliable vectors enable:
- Strong and reliable transduction efficiency
- Consistent transgene expression
- Reproducible experimental outcomes
- Faster troubleshooting and reduced development timelines
- More efficient pathways to manufacturing scale-up
In other words:
Good science needs good delivery systems.
Why Choose Tailored Genes for your CART–T Program
We provide end-to-end support for your CAR-T development process, combining advanced technology, rigorousquality standards, and experienced scientific expertiseto ensure reliable and efficient results. Our commitment to innovation, compliance, and timely delivery helps bring your cell therapy solutions to market with confidence.
- North American Manufacturing – this ensures stringent quality standards to support reliability and consistency.
- Fast Turnaround Times – Efficient project execution helps keep development timelines on track.
- Satisfaction-Focused Partnership – We remain engaged after delivery to ensure project success and address any challenges that arise.
- Built for Research Success – Our goal is to help your team move forward with confidence, from early development stage through scale-up.
Our Solutions
Explore More Manufacturing Solutions
Expertly crafted virus vectors and cell line solutions—powering research from bench to breakthrough.
Adeno-Associated Virus (AAV)
High titer (10¹³ and 10¹⁴ GC/mL) and ultra pure AAV vectors.
Lentivirus Vectors
High titer (10⁸–10⁹ IU/mL) and high purity LV vectors.
Covid-19 Vectors
Safe vectors with variant COVID-19 spikes to study entry and test antivirals.
